Skip to content

Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique

Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02271100
Enrollment
110
Registered
2014-10-22
Start date
2016-10-25
Completion date
2025-01-01
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain

Brief summary

This study is intended to determine whether ultrasound imaging can improve the ability to place a spinal or epidural needle in obstetric anesthesia. By evaluating the use of ultrasound for the placement of epidural catheters the investigators hope to answer two questions: 1\. How does the traditional technique based on palpation compare to one using ultrasound to place an epidural catheter? 2. Does ultrasound reduce one potential risk in epidural placement?

Detailed description

This study contains two phases: 1. A prospective, randomized, blinded comparison of ultrasound imaging versus palpation for epidural catheter insertion in laboring women. 2. A prospective, single cohort, blinded trial to assess whether ultrasound imaging provides a reliable placement below the L3 vertebra. The initial phase of the investigation will be a randomized comparison of ultrasound versus palpation. Patients will be enrolled in early labor and will be randomized to have their epidural placed with either technique. The technique will be chosen by computer-generated randomization list maintained in opaque sequentially numbered envelopes. Description of the placement technique is below. The primary outcome will be the number of epidural catheters inserted above the intended insertion site. The investigators will also assess the total time required for epidural catheter placement, number of attempts for successful insertion, effectiveness of the epidural catheter for labor pain control. Following completion of enrollment of the first phase, the second phase of the investigation will enroll patients only into the single-cohort ultrasound arm. The study will use the same methodology as the initial phase, but without randomization due to a single cohort. The primary outcome will be the absolute number of epidural catheters inserted above the L3 vertebral body. The investigators will also assess the effectiveness of the ultrasound markings for guiding placement. Procedure placement technique After written, informed consent, and standard patient preparation, the epidural catheter will be placed with the patient in the sitting position by a junior resident. In the ultrasound arm, the patient will be first imaged using an appropriate probe, and the identified ultrasound landmarks marked on the skin. The skin will be prepped in the usual fashion, and the needle will be inserted at the identified site and direction determined by ultrasound. In the palpation arm, the skin will be prepped and the needle will be inserted using palpation-identified landmarks to guide the needle. All catheters will be intended to be placed at the L4-L5 interspace as the primary attempt. The L3-L4 interspace will be used as a secondary attempt. Assessment of final position After insertion of the epidural catheter and administration of the pain relief medication, patients in both groups will be examined by a blinded observer using ultrasound to determine the catheter insertion site and the likely insertion interspace. If, however, the investigators discover that the use of ultrasound for placement of the epidural catheter may present greater risk than previously anticipated to the pregnant woman or fetus, then the investigators will stop the study after phase 1 and not proceed with phase 2.

Interventions

use of ultrasound for entry position estimation

DEVICEpalpation guidance

use of palpation for position estimation

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

randomized blinded comparison of two methods to identify landmarks for a procedure

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy ASA I or II parturient * Will be receiving neuraxial placement for labor, having been consented for the procedure

Exclusion criteria

* ASA III or IV * Unable to participate in the study due to severe pain * Contraindications to neuraxial analgesia * Previous spinal surgery in the lumbar or sacral area (L1 through Sacrum) * BMI greater than 37 * Height less than 60 inches * Significant scoliosis

Design outcomes

Primary

MeasureTime frameDescription
Placement Below L3 Vertebraimmediately post epidural catheter placementPercentage of participants with catheters placed below the L3 Vertebra

Secondary

MeasureTime frameDescription
Time to PlacementDuring the procedureThe time in minutes for completion of the procedure measured from the start of the procedure defined as administration of the first medication until the epidural test dose was administered
Success of the Epidural Catheter Placementimmediately post epidural catheter placement up to 30 minutesRelief of labor pain defined by verbal pain score less than 4 after administration of medication; verbal pain score consisted of a scale from 0 to 10 with 0 representing no pain and 10 representing worst possible pain, with higher numbers representing greater pain felt by the patient

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPhilip E Hess, MD

Beth Israel Deaconess Medical Center

Baseline characteristics

Characteristic
Age, Continuous33.5 years
STANDARD_DEVIATION 5
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
43 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Nulliparity56 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
16 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
60 Participants
Sex: Female, Male
Female
49 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 510 / 49
other
Total, other adverse events
0 / 510 / 49
serious
Total, serious adverse events
0 / 510 / 49

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026